Détail de l'auteur
Auteur B. KILMER |
Documents disponibles écrits par cet auteur (36)
Rapport
B. KILMER ; S. DAVENPORT ; R. SMART ; J. P. CAULKINS ; G. MIDGETTE | Santa Monica, CA : Rand Corporation | Research Reports | 2019* Research Questions: What types of cannabis products are produced and sold in Washington State? What is the size of the cannabis market in Washington State three years after licensing cannabis production and sales for nonmedical purposes? * [...]Rapport
B. KILMER ; J. P. CAULKINS ; R. L. PACULA ; R. J. MACCOUN ; P. H. REUTER | Santa Monica, CA : Rand Corporation | Occasional Papers | 2010To learn more about the possible outcomes of marijuana legalization in California, RAND researchers constructed a model based on a series of estimates of current consumption, current and future prices, how responsive use is to price changes, tax[...]Rapport
P. H. REUTER ; F. TRAUTMANN ; R. L. PACULA ; B. KILMER ; GAGELDONK A. ; D. VAN DER GOUWE | Santa Monica, CA : Rand Corporation | Technical Reports | 2009This report provides key findings of the RAND Europe study which assesses how the global market for illicit drugs has developed from 1998 to 2007 and describes worldwide drug policies implemented during that period to address the problem. The st[...]Article : Périodique
S. DAVENPORT ; M. ROBBINS ; M. CERDA ; A. RIVERA-AGUIRRE ; B. KILMER |BACKGROUND AND AIMS: Debates regarding lowering the blood alcohol concentration (BAC) limit for drivers are intensifying in the United States and other countries, and the World Health Organization recommends that the limit for adults should be 0[...]Rapport
B. KILMER ; J. P. CAULKINS ; G. MIDGETTE ; L. DAHLKEMPER ; R. J. MACCOUN ; R. L. PACULA | Santa Monica, CA : Rand Corporation | Research Reports | 2013In 2012, Washington state voters passed Initiative 502 (I-502), which removed the prohibition on the production, distribution, and possession of marijuana for nonmedical purposes and required the state to regulate and tax a new marijuana industr[...]Article : Périodique
Having a sense of the scale of an illicit drug market is important for projecting consequences of alternative policy regimes. In this article, we review two general approaches to drug market estimation - supply-side and demand-side - before turn[...]Article : Périodique
Aims: Drug policy strategies and discussions often use prevalence of drug use as a primary performance indicator. However, three other indicators are at least as relevant: the number of heavy users, total expenditures and total amount consumed. [...]Rapport
Rapport
B. KILMER ; J. TAYLOR ; J. P. CAULKINS ; P. A. MUELLER ; A. J. OBER ; B. PARDO ; R. SMART ; L. STRANG ; P. H. REUTER | Santa Monica, CA : Rand Corporation | Research Reports | 2018Current levels of opioid-related morbidity and mortality in the United States are staggering. Data for 2017 indicate that there were more than 47,000 opioid-involved overdose deaths, and one in eight adults now reports having had a family member[...]Article : Périodique
Background and Aims: In 2014 the legislature of Vermont, USA passed a law requiring the Secretary of Administration to report on the consequences of legalizing marijuana. The RAND Corporation was commissioned to write that report. This paper sum[...]Rapport
J. P. CAULKINS ; B. KILMER ; M. A. R. KLEIMAN ; R. J. MACCOUN ; G. MIDGETTE ; P. OGLESBY ; R. L. PACULA ; P. REUTER | Santa Monica, CA : Rand Corporation | Research Reports | 2015Marijuana legalization is a controversial and multifaceted issue that is now the subject of serious debate. Since 2012, four U.S. states have passed ballot initiatives to remove prohibition and legalize a for-profit commercial marijuana industry[...]Rapport
Changing patterns in drug use and supply can affect the well-being and development of Asian countries in many ways: The burden of disease from injection drug use, overreliance on the criminal justice system, and rise of drug-related crime can im[...]Article : Périodique
Aims No modern jurisdiction has ever legalized commercial production, distribution and possession of cannabis for recreational purposes. This paper presents insights about the effect of legalization on production costs and consumption and highli[...]Article : Périodique
Until November 2012, no modern jurisdiction had removed the prohibition on the commercial production, distribution, and sale of marijuana for nonmedical purposes - not even the Netherlands. Government agencies in Colorado and Washington are now [...]Rapport
F. TRAUTMANN ; B. KILMER ; P. TURNBULL | Bruxelles : Commission européenne, Direction générale justice et affaires intérieures, Coordination de la lutte anti-drogue | 2013Highlights [Extracts]: * Our estimates for the EU cannabis market suggest a range of approximately €7 billion to €10 billion for 2010. These estimates are likely low as they do not account for the "consumption gap" that is created when data fro[...]Article : Périodique
BACKGROUND: Marijuana contains multiple cannabinoids. Most attention is given to delta-9-tetrahydrocannabinol (THC) which produces euphoria and in some cases anxiety and panic reactions. Research suggests that another cannabinoid, cannabidiol (C[...]Rapport
Article : Périodique
J. P. CAULKINS ; B. PARDO ; B. KILMER |Background: Drug use is often measured in terms of prevalence, meaning the number of people who used any amount in the last month or year, but measuring the quantity consumed is critical for making informed regulatory decisions and estimating th[...]Livre
J. P. CAULKINS ; A. HAWKEN ; B. KILMER ; M. A. R. KLEIMAN | Oxford - New York : Oxford University Press | What everyone needs to know | 2012Should marijuana be legalized? The latest Gallup poll reports that exactly half of Americans say "yes"; opinion couldn't be more evenly divided. Marijuana is forbidden by international treaties and by national and local laws across the globe. B[...]Rapport
J. P. CAULKINS ; K. FURLONG ; B. McCOMAS ; M. NOGUEIRA DOMINGUES ; A. SIDDIQUE ; B. KILMER | Lisbon : OEDT / EMCDDA | Insights, ISSN 1606-1683 | 2022This chapter explores two methods of bringing together the complementary strengths of general population surveys (GPS) and web surveys to develop improved estimates of overall quantities of drugs consumed — namely, raking and regression. Raking [...]Rapport
B. KILMER ; K. KRUITHOF ; M. PARDAL ; J. P. CAULKINS ; J. RUBIN | Santa Monica, CA : Rand Corporation | Research Reports | 2013In July 2013, the Research and Documentation Centre (WODC) of the Netherlands Ministry of Security and Justice asked RAND Europe to provide a multinational overview of cannabis production regimes, with a special focus on identifying and describi[...]Rapport
As more jurisdictions contemplate and pass laws to legalise cannabis for medical and non-medical purposes, the discussions about cannabis policy will likely become more intense in the EU. Member States can learn from these experiences and decide[...]Rapport
J. P. CAULKINS ; B. KILMER ; M. A. R. KLEIMAN ; R. J. MACCOUN ; G. MIDGETTE ; P. OGLESBY ; R. L. PACULA ; P. H. REUTER | Santa Monica, CA : Rand Corporation | Perspectives | 2015Marijuana legalization is a controversial and multifaceted issue that is now the subject of serious debate. Since 2012, four U.S. states have passed ballot initiatives to remove prohibition and legalize a for-profit commercial marijuana industry[...]Article : Périodique
The cannabis policy landscape is changing rapidly. In November 2012 voters in Colorado and Washington State passed ballot initiatives to remove the prohibition on the commercial production, distribution, and possession of cannabis. This paper do[...]Article : Périodique
Twenty percent of the U.S. population now lives in states that have passed ballot initiatives to allow cannabis to be sold for recreational use. The net effect of cannabis legalization on public health is uncertain, and much will depend on how t[...]